Literature DB >> 18496051

Application of automatic vertical positioning software to reduce radiation exposure in multidetector row computed tomography of the chest.

Jianhai Li1, Unni K Udayasankar, Thomas L Toth, William C Small, Mannudeep K Kalra.   

Abstract

OBJECTIVE: To determine the effect of automatic vertical positioning (AVP) software on radiation dose reduction in multidetector row computed tomography of the chest.
MATERIALS AND METHODS: Two hundred forty-three consecutive patients (mean age, 54; range, 20-93 years), who underwent 64-slice multidetector row computed tomography of the chest from November 2005 to April 2006, were included in this study. This study was approved by our institutional review board with waiver of informed consent. Technologists initially positioned the patient in the gantry by adjusting the table height (vertical positioning) using a laser guidance system and patient surface anatomy. AVP software was then used to determine the true vertical positioning of the patient based on matching the individual patient's mean centroid (center of mass) throughout the chest as determined by the lateral projection with the gantry isocenter and center of the bow-tie filter. The resultant reduction in surface radiation dose with this attenuation-based vertical positioning was then calculated. Software-determined changes in patient vertical positioning and resultant radiation dose savings were analyzed using the t test and Pearson correlation statistics.
RESULTS: Vertical positioning of the patients by the technologist differed from AVP with the bow-tie filter in 95.5% (232 of 243) of patients with an average vertical mispositioning distance of 33.2 +/- 1.1 mm (range, 5.1-97 mm). Among mispositioned patients, 97% (225 of 232) were vertically mispositioned below the isocenter with a mean distance of 33.8 +/- 1.1 mm (range, 5.1-97 mm) and 3% (7 of 232) patients were vertically mispositioned above the isocenter, with a mean distance of 12.7 +/- 2.8 mm (range, 6-28 mm). The average surface radiation dose reduction with AVP software was 19% +/- 1% (range, 1%-46.6%). There was a strong correlation between vertical mispositioning distance and the surface radiation dose reduction facilitated by AVP software (r(2) = 0.9, P < 0.001).
CONCLUSION: AVP software can help in optimum patient vertical positioning leading to substantial reduction in surface radiation dose.

Entities:  

Mesh:

Year:  2008        PMID: 18496051     DOI: 10.1097/RLI.0b013e318169005e

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  6 in total

Review 1.  [Strategies for reducing the CT radiation dose].

Authors:  S T Schindera; C Nauer; R Treier; P Trueb; G von Allmen; P Vock; Z Szucs-Farkas
Journal:  Radiologe       Date:  2010-12       Impact factor: 0.635

2.  An education and training programme for radiological institutes: impact on the reduction of the CT radiation dose.

Authors:  Sebastian T Schindera; Reto Treier; Gabriel von Allmen; Claude Nauer; Philipp R Trueb; Peter Vock; Zsolt Szucs-Farkas
Journal:  Eur Radiol       Date:  2011-05-31       Impact factor: 5.315

3.  [Current strategies for dosage reduction in computed tomography].

Authors:  M S May; W Wuest; M M Lell; M Uder; W A Kalender; B Schmidt
Journal:  Radiologe       Date:  2012-10       Impact factor: 0.635

4.  Abdominal CT during pregnancy: a phantom study on the effect of patient centring on conceptus radiation dose and image quality.

Authors:  G Solomou; A E Papadakis; J Damilakis
Journal:  Eur Radiol       Date:  2014-11-28       Impact factor: 5.315

5.  Ablation margin assessment of liver tumors with intravenous contrast-enhanced C-arm computed tomography.

Authors:  Mi Sung Kim; Sarabjeet Singh; Elkan Halpern; Sanjay Saini; Mannudeep K Kalra
Journal:  World J Radiol       Date:  2012-03-28

6.  Accuracy of automated patient positioning in CT using a 3D camera for body contour detection.

Authors:  Ronald Booij; Ricardo P J Budde; Marcel L Dijkshoorn; Marcel van Straten
Journal:  Eur Radiol       Date:  2018-10-10       Impact factor: 5.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.